ASC Durango (Colo.) recently underwent its first AAAHC survey and achieved accreditation. During the survey, it was brought to the attention of Cheryl Desko, RN, clinical director for the ASC, that ...
Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results